Objective: Traditional two-dimensional (2D) cell culture of adipose-derived stem cells (ADSCs) to halt stress urinary incontinence (SUI) progression have low retention rate and limited function recuperation poorly mimicking in vivo conditions. This study aims to examine the potential and mechanism of three-dimensional (3D) cultures of ADSCs in the treatment of SUI in a rat model simulating childbirth injury. Methods: ADSCs were used to generate microtissues (MTs) with a hanging drop method. A total of 48 postpartum Sprague-Dawley rats were developed SUI models by 4 hours vagina dilation (VD) followed by bilateral ovariectomy (OV). Ten rats underwent sham OV without VD served as control group. The SUI rats were divided into three groups and received urethral injection of PBS, ADSCs and MTs. Specimens were harvested for histology examination and ADSCs tracking at day 1, 3, 7, 28 (n=3) post-injection. At day 28, the remaining rats were examined for voiding function. Western blot, immunofluorescence and immunohistochemistry staining were performed to examine histological changes and cytokines expression. Results: The voiding function and histopathological structures were better recovered in MTs group than those in ADSCs group. Compared with ADSCs, MTs express higher level of vascular endothelia growth factor (VEGF), TNFα stimulated gene/protein 6 (TSG-6) in vitro and represented a higher retention rate in vivo. Conclusions: Urethral injection of MTs better restored the voiding function than ADSCs. Objective: RNF2 is frequently overexpressed in several types of human cancer, but the status of RNF2 amplification and expression in urothelial carcinoma of the bladder (UCB) and its clinical/prognostic significance is unclear. Methods: In this study, the methods of immunohistochemistry and fluorescence in situ hybridization (FISH) were utilized to examine the protein expression and amplification of RNF2 in 184 patients of with UCBs who underwent radical cystectomy. Results: Overexpression of RNF2 was found in 44.0% of UCBs. A highly significant association between overexpression of RNF2 with shortened patient overall and cancer specific survival (P<0.001, logrank test) was demonstrated. In different subsets of UCB patients, overexpression of RNF2 was also a prognostic indicator in patients with pT1, pT2, pN(-) and/or negative surgical margins (P<0.05). Importantly, RNF2 expression together with pT status and surgical margins status provided significant independent prognostic parameters in multivariate analysis (P<0.05). Additionally, a significant correlation (P=0.003) of overexpression of RNF2 with an increased UCB labeling index of Ki-67 was observed in this UCB cohort. FISH results showed that the amplification
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Sun Yat-sen University Cancer Center, Guangzhou 510060, China Objective: RNF2 is frequently overexpressed in several types of human cancer, but the status of RNF2 amplification and expression in urothelial carcinoma of the bladder (UCB) and its clinical/prognostic significance is unclear. Methods: In this study, the methods of immunohistochemistry and fluorescence in situ hybridization (FISH) were utilized to examine the protein expression and amplification of RNF2 in 184 patients of with UCBs who underwent radical cystectomy. Results: Overexpression of RNF2 was found in 44.0% of UCBs. A highly significant association between overexpression of RNF2 with shortened patient overall and cancer specific survival (P<0.001, logrank test) was demonstrated. In different subsets of UCB patients, overexpression of RNF2 was also a prognostic indicator in patients with pT1, pT2, pN(-) and/or negative surgical margins (P<0.05). Importantly, RNF2 expression together with pT status and surgical margins status provided significant independent prognostic parameters in multivariate analysis (P<0.05). Additionally, a significant correlation (P=0.003) of overexpression of RNF2 with an increased UCB labeling index of Ki-67 was observed in this UCB cohort. FISH results showed that the amplification of RNF2 was examined in 8/79 (10.1%) of informative UCB cases; in each of the 7 cases with RNF2 amplification, overexpression of RNF2 was observed. In the remaining 71 informative cancers without RNF2 amplification, 25 (35.2%) cases showed overexpression of RNF2. Conclusions: our findings suggested that overexpression of RNF2, as examined by immunohistochemistry, might serve as a novel prognostic biomarker and potential therapeutic target for UCB patients treated with radical cystectomy. Objective: The coiled-coil is a superhelical structural protein motif involved in a diverse array of biological functions, and the abnormal expression of the coiledcoil domain containing proteins has a direct link with the phenotype of tumor cell migration, invasion and metastasis. Here, we first reported the oncogenic roles of coiled-coil domain-containing protein 34 (CCDC34), and investigated its biological functions in bladder carcinogenesis. Methods: Immunohistochemical staining, western blot and quantitative RT-PCR were used to detect CCDC34 expression in bladder cancers specimens and cell lines. Lentivirus-mediated RNA interference strategy was used to assess the effects of CCDC34 expression on various malignant phenotypes. The biological functions of CCDC34 knockdown on cells (T24 and 5637) were investigated by examining cell proliferation using a high content screening assay (HCS), BrdU incorporation assay and colony formation assay, cell migration by in vitro wound healing assay, cell invasion by Transwell invasion assay, as well as cell cycle distribution and apoptosis by flow cytometry. The expressions of c-Raf and c-Jun as well as the phosphorylation of MEK, ERK1/2, JNK, P38 and AKT were also measured using Western blot. We further investigated the effect of therapeutic siRNA targeting CCDC34 on T24 xenograft tumor growth in nude mice. Results: CCDC34 was up-regulated in human bladder cancer tissues and cell lines. CCDC34 was distributed mainly in the cytoplasm, and its expression was not correlated with gender, histological type and tumor grade, but was closely correlated with pathologic stage (n=87, P<0.05). Besides, Western blot confirmed that CCDC34 was expressed at higher level in human bladder cancer tissues compared with their paraneoplastic normal bladder tissues (n=18, P=0.012). Knockdown of CCDC34 significantly suppressed bladder cancer cells proliferation, migration and invasion (P<0.01), and induced cell cycle arrest at G2/M phase and increased apoptosis in vitro (P<0.01). Moreover, CCDC34 knockdown decreased phosphorylation of MEK, ERK1/2, JNK, p38 and AKT, and the expressions of c-Raf, c-Jun and Bcl-2. In addition, intratumor delivery of therapeutic siRNA targeting CCDC34 elicited delayed tumor growth of T24 xenograft in nude mice. Conclusions: Our findings revealed for the first time a potential oncogenic role for CCDC34 in bladder carcinoma pathogenesis, and the MAPK and AKT signaling pathways might be involved in CCDC34 modulation of bladder cancer cell proliferation, migration and invasion. CCDC34 may serve as a biomarker or even a therapeutic target for bladder cancer.
